LAMEA Polymerase Chain Reaction Technologies Market Size to register a growth of 6.8% CAGR

20-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Polymerase Chain Reaction Technologies Market, published by KBV research, the LAMEA Polymerase Chain Reaction Technologies Market would witness market growth of 6.8% CAGR during the forecast period (2018 – 2024).

The Brazil market would dominate the LAMEA Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by Country by 2024, growing at a CAGR of 7 % during the forecast period. The Argentina market is expected to witness a CAGR of 6.9% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 4.3% during (2018 - 2024).

The Forensics market dominated the LAMEA Polymerase Chain Reaction Technologies Market by Application in 2017. The Research market is expected to witness a CAGR of 7.3% during (2018 - 2024). Additionally, The Clinical market is expected to witness highest CAGR of 6.6% during (2018 - 2024).

The Reagents & Consumables market dominated the UAE Polymerase Chain Reaction Technologies Market by Product in 2017, and would achieve a market value of $67.2 million by 2024. The Services market is expected to witness a CAGR of 6.5% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/lamea-polymerase-chain-reaction-technologies-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.